‡a
Author's A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
‡a
novelurinarymrnasignatureusingthedropletdigitalpolymerasechainreactionplatformimprovesdiscriminationbetweenprostatecancerandbenignprostatichyperplasiawithintheprostatespecificantigengrayzone
‡A
A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
‡9
1